Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Durvalumab 1500 / Tarlatamab 10, Small Cell Lung Cancer, Cycle 2+

Protocol-ID: 3285 V1.0 (Mini), DURV1500/TARL10, SCLC, C2+

Indication(s)

  • Lung Carcinoma, Small Cell; ICD-10 C34.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician.

Valid since: 17.11.2026